A New Way of
Diabetes Management
GluCare.Health patients are getting results, Fast.
We follow a clinical outcome based approach
& transparently report clinical results.
GluCare.Health has reduced many other risks closely associated with Diabetes
in as little as 90 days.
%
⇩ Inflammation
%
⇩ Cholestrol LDL
%
⇧ Cholestrol HDL
%
⇩ Uric Acid
%
⇩ Body Weight
%
⇩ Cardiovascular
Over 2.1% reduction in HbA1c in just 90 days.
GluCare.Health patients have vastly better outcomes (in just 90 days) across a range of cardiometabolic parameters. Meanwhile patients receiving usual or traditional care saw no improvement or worsening of their condition with time.
RESULTS | Glucare | Usual Care | Usual Care |
HbA1c ⇩ | - 2.14% | 0.05% | + 0.20% |
CVD Risk ⇩ | - 39.03% | - | - |
BMI ⇩ | - 4.49% | - | - |
Body Weight ⇩ | - 4.49% | 0 | 0 |
Waist Circumference ⇩ | - 5.15% | - | - |
Triglycerides ⇩ | - 18.52% | 2.50% | + 10% |
LDL ⇩ | - 17.25% | - 2.75% | + 11% |
HDL ⇧ | + 5.19% | - 0.75% | - 3% |
ATL ⇩ | - 9.44% | - 0.50% | - 2% |
Uric Acid ⇩ | - 20.40% | - 1% | - 4% |
hsCRP ⇩ | - 6.19% | 3.75% | + 15% |
GluCare 90-Day Outcomes where signicantly different from baseline (p<0.05) for HbA1c, CV Risk, BMI, Body Weight, Wast Circumference, Triglycerides, LDL, Uric Acid.
For full details: Caccelli et al, Diabetes Manag (2021) 11(9), 290-296, Usual Care DOI: 10.1107/s 13300-018-0373-9
GluCare.Health reduces the need for prescription medication
Percentage Reduction Over 12 Months
100% on Insulin Medication
↓ Down to 60% usage in 3 Months
↓ Down to 43% usage in 6 Months
↓ Down to 18% usage in 9 Months
↓ Down to 4% usage in 12 Months
100% on Metformin Medication
↓ Down to 51% usage in 3 Months
↓ Down to 26% usage in 6 Months
↓ Down to 14% usage in 9 - 12 Months
100% on DPP4 Medication
↓ Down to 23% usage in 3 Months
↓ Down to 8% usage in 6 Months
100% Reduction in 9 Months
↓ Down to 54% usage in 3 Months
100% on SGLT2 Medication
↓ Down to 18% usage in 6 Months
↓ Down to 12% usage in 9 Months
↓ Down to 12% usage in 6 Months
↓ Down to 6% usage in 12 Months
100% on Sulfonyerea Medication
↓ Down to 19% usage in 3 Months
100% Reduction in 9 Months
What a reduction of 1% in HbA1c means
for other complications
%
⇩ End-Point Disease Related to Diabtes
%
⇩ Death Related to Diabetes
%
⇩ Heart Attack
%
⇩ Microvascular Complication
%
⇩ End-Point Disease Related to Diabtes
%
⇩ Death Related to Diabetes
%
⇩ Heart Attack
%
⇩ Microvascular Complication
Association of Glycaemia with microcvascular complications of type 2 diabetes (UKPDS 35): prospective observation study.
Association of Glycaemia with microcvascular complications of type 2 diabetes (UKPDS 35): prospective observation study.
